Extrauterine Growth Restriction and Optimal Growth of Very Preterm Neonates: State of the Art

Nutrients. 2023 Jul 21;15(14):3231. doi: 10.3390/nu15143231.

Abstract

Over the last few decades, there has been an ongoing debate over both the optimal feeding mode for very premature neonates (VPN) as well as what their optimal growth should be. Despite the American Academy of Pediatric declaring since 1997 that the growth of VPN should follow the trajectory of intrauterine fetal growth, differences of opinion persist, feeding policies keep changing, and the growth and development of VPN remains extremely variable not only between countries, but even between neighboring neonatal units. Even the appropriate terminology to express poor postnatal growth (extrauterine growth restriction (EGR) and postnatal growth failure (PGF)) remains a subject of ongoing discussion. A number of recent publications have shown that by implementing breast milk fortification and closely following growth and adjusting nutrition accordingly, as per the consensus guidelines of the major Neonatal Societies, we could achieve growth that closely follows birth centiles. A recent position paper from EPSGAN recommending targeted nutritional support to cover the energy and protein deficits sustained by VPN during periods of critical illness further strengthens the above findings. Conclusion: We can promote better growth of VPN by ensuring a stable administration of sufficient calories and protein, especially in the first 2 weeks of life, implementing breast milk fortification, covering energy and protein deficits due to critical illness, and increasing feeding volumes as per the latest guidelines. The adoption of universal protocol for nutrition and growth of VPN is essential and will enable better monitoring of long-term outcomes for this population.

Keywords: extrauterine growth restriction; feeding policies; nutrition; optimal growth; postnatal growth failure; very premature neonates.

MeSH terms

  • Child
  • Critical Illness*
  • Enteral Nutrition / methods
  • Female
  • Humans
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Milk, Human
  • Proteins

Substances

  • Proteins

Grants and funding

This research received no external funding.